
CuriRx, Inc.
Wilmington, MA, United States curirx.com From their website, Nov 2026
Work here? Claim this listing
About
CuriRx, Inc. is a pharmaceutical CDMO in Wilmington, Massachusetts. It provides formulation, bioprocessing, analytical, quality testing, and CMC support services for biopharmaceuticals, biologics, small molecules, and gene therapy products.
Services
Formulation Development
Develops pharmaceutical formulations for injectables and other dosage forms, including liquid, lyophilized, nanoparticle, microemulsion, nanoemulsion, and complexation formats.
Formulation Studies
Performs preformulation studies such as Stability Fingerprinting® for biotherapeutics and Solubility Fingerprinting® for small molecules.
Lyophilization
Supports lyophilized product development for stability, transport, storage, and clinical progression.
Nanotechnology
Develops lipid nanoparticle-based delivery systems for mRNA, DNA, ADCs, antibodies, small molecules, and other modalities.
Advanced Bioprocessing
Provides end-to-end bioprocessing development spanning cell line and strain development, upstream process development, and downstream process development.
Protein production
Cell Line and Strain Development
Develops production strains and expression systems using GS, DHFR, CHO, E. coli, yeast, and transient transfection approaches.
Upstream Process Development
Develops and scales cell culture processes from vector construction through harvest, including media, feed, and bioreactor condition optimization.
Protein production
Downstream Process Development
Develops purification and viral clearance workflows using chromatography, filtration, and related purification steps.
Protein production
10 more services
- Analytical Services
- CuriLytics® CMC Analytical Support
- High Resolution Mass Spectrometry
- CMC Support Services
- Analytical Testing Services
- Quality Testing
- Prefilled Syringes
- CMC Analytical Support
- Qualification and Validation
- Stability Studies
Capabilities
- Assays and studies
- Process development
- Antibodies
- Lyophilization
- Peptides
- Small molecules
- Stability studies
22 more
- Analytical development
- ADCs
- Solubility Fingerprinting®
- Stability Fingerprinting®
- Peptide mapping
- Protein identification
- Antibody/protein characterization
- Protein post-translational modification analysis
- Disulfide bond mapping
- Glycan profiling
- Host cell protein analysis
- Release testing
- Stability testing
- Method development
- Method transfer
- Method validation
- Method qualification
- Post-translational modification analysis
- Protein aggregation analysis
- Protein quantitation
- Product release testing
- API release testing
- Scale and capacity
- 1L to 10L bioreactors
- 250 mL to 40 L scale single-use bioreactors
- 9x3L bioreactors
- 8x1-2L parallel bioreactors
- Therapeutic areas
- Biopharmaceuticals
- Biologics
- Gene therapy
Instruments and platforms
- LyoStar II-FTS Lyophilizer
- FACS
- Cell imager
- CEDEX
- NOVA Bioprofile
- NOVA CDV
8 more
- AKTA pure
- AKTA Prime Plus
- AKTA Pilot
- High resolution mass spectrometry
- LC/MS
- RP LC/MS/MS
- SEC-HPLC
- SEC-HRMS
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- ADC
- Peptide
- Oligonucleotide
4 more
- mRNA
- Viral vector
- Vaccine
- LNP / formulation
- Species and models
- CHO
- ExpiCHO
- CHOK1
- CHOZN
- E. coli
- Yeast
5 more
- Saccharomyces cerevisiae
- Pichia pastoris
- Insect
- Mammalian
- Bacterial
Industries served
- Pharmaceuticals
- Biotechnology
Details
- Type
- CRDMO
- Quality
- USP 1055 · ICH Q6B (CMC support and analytical characterization) · ICH guidelines (stability studies) · NDA · BLA · ANDA · 505(b)(2)
- Based in
- Wilmington, MA, United States
- Phone
- 978-658-2962